The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Biotechnology's rapid development of the future of medicine shows little sign of slowing down. We speak to the International ...

Importantly, BGE-102 is an oral candidate. The current leaders in the anti-obesity market are administered via subcutaneous ...

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher Scientific, unpacks the evolving landscape of precision therapeutic and ...

Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.

Shares of Praxis Precision Medicine shot 251% higher in a little over a week during the month of October. Praxis Precision ...

A new study published in Nature Biotechnology shows that stem cell differentiation is linked to cellular structures called ...

Krystal Biotech, Inc. announced that it will present multiple research programs focused on lung, eye, and skin conditions at several scientific conferences in May and June 2025. The presentations ...

The 3D cell culture market is projected to witness remarkable expansion, reaching an estimated USD 2.26 billion by 2030 from ...

Despite hitting a clinical “milestone,” Prime Medicine is shelving its sole clinical-stage genetic medicine. The Cambridge, Massachusetts-based biotech is also laying off staffers and CEO Keith ...

TNBC: Based on the results of the multicenter, randomized, controlled Phase III OptiTROP-Breast01 (NCT05347134) clinical study, the current publication reports on the efficacy and safety of sac-TMT ...